A large-scale study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, ...
Of 16,732 patients with metastatic prostate cancer who died after being diagnosed between 2000 and 2016, nearly 17 percent died from other causes, according to a study published Aug. 5 in JAMA Network ...
While prostate cancer recurrence is a major cause of death in patients receiving localized treatment, there are other significant causes of mortality. While prostate cancer progression or recurrence ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
A new way to prevent excruciating pain from the side effects of advanced prostate cancer therapy has been developed.Many men ...
When Less Can Be More: How the 10-Year Updated Results From the Randomized Controlled AMAROS Trial Should Affect Axillary Management in the Setting of a Positive Node Supported in part by the National ...
In recent weeks, two prominent men, Britain's King Charles and Defense Secretary Lloyd Austin, revealed they were dealing with prostate issues. CBS News chief medical correspondent Dr. Jon LaPook ...
Orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...
Academics from the University of Bedfordshire have worked with other experts on new research into prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback